Botanical species · safety record

Brugmansia suaveolens

The EFSA Compendium of Botanicals holds 18 constituent measurements and 2 adverse-effect records for Brugmansia suaveolens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Brugmansia suaveolens (Humb. & Bonpl. ex Willd.) Bercht. & J.Presl

18Constituent measurements

2Safety records

8Cited sources

0Licensed products (Canada)

Also recorded as

Datura suaveolens Humb. & Bonpl. ex Willd.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Scopolamine	Flower	Solvent extraction	≥ 1.3 Milligram/gram	—	Resolve DOI
Scopolamine	Flower	Solvent extraction	≤ 1.5 Milligram/gram	—	Resolve DOI
Scopolamine	Fruit unspecified	Solvent extraction	≥ 1.8 Milligram/gram	—	Resolve DOI
Scopolamine	Fruit unspecified	Solvent extraction	≤ 2 Milligram/gram	—	Resolve DOI
Scopolamine	Leaves	Solvent extraction	≥ 0.8 Milligram/gram	—	Resolve DOI
Scopolamine	Leaves	Solvent extraction	≤ 1.1 Milligram/gram	—	Resolve DOI
Scopolamine	Roots and other underground parts	Solvent extraction	≥ 0.1 Milligram/gram	—	Resolve DOI
Scopolamine	Roots and other underground parts	Solvent extraction	≤ 0.3 Milligram/gram	—	Resolve DOI
Scopolamine	Stem / stalk	Solvent extraction	≥ 0.8 Milligram/gram	—	Resolve DOI
Scopolamine	Stem / stalk	Solvent extraction	≤ 1 Milligram/gram	—	Resolve DOI
1,8-cineole	Flower	Solvent extraction	≥ 2 Percent	GC-MS	No resolvable identifier
1,8-cineole	Flower	Solvent extraction	≤ 72.1 Percent	GC-MS	No resolvable identifier
Alkaloids	Flower	Solvent extraction	0.64 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Scopolamine	Flower	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Scopolamine	Leaves	Solvent extraction	80 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Tropane alkaloids	Live plants	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Tropane alkaloids	Stem / stalk	Solvent extraction	2.37 Percent	Unspecified	No resolvable identifier
Tropane alkaloids	Leaves	Solvent extraction	0.318 Percent	Unspecified	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Neurotoxicity	Neurologic	Flower	—	Human (as organism)	Case report	Resolve DOI
Neurotoxicity	Neurologic	Unspecified	Thermal treatment (heating for preservation)	Human (as organism)	Case report	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Chang, S.-S., Wu, M.-L., Deng, J.-F., Lee, C.-C., Chin, T.-F., Liao, S.-J. Poisoning by Datura leaves used as edible wild vegetables. Veterinary and Human Toxicology, 1999, vol. 41, no. 4, p. 242-245.
Anthony, Samuel J., Zuchowski, Willow., Setzer, William N. Composition of the Floral Essential Oil of Brugmansia suaveolens. Records of natural products, 2009, vol. 3, no. 2, p. 76-81.
Sevketoglu, Esra., Tatli, Burak., Tugcu, Betul., Demirelli, Yasar., Hatipoglu, Sami. An Unusual Cause of Fulminant Guillain-Barre Syndrome: Angel's Trumpet. PEDIATRIC NEUROLOGY, 2010, vol. 43, no. 5, p. 368-370. DOI
Evans, W. C., Lampard, J. F. Alkaloids of the genus Datura section Brugmansia. VIII. Alkaloids of Datura suaveolens. Phytochemistry (Elsevier), 1972, p. 3293-3298.
Kerchner Andras., Darok Judit., Bacskay Ivett., Felinger Attila., Jakab Gabor., Farkas Agnes. Protein and alkaloid patterns of the floral nectar in some solanaceous species. Acta biologica hungarica, 2015, p. 304-315.
Alves, Marcos Nopper., Sartoratto, Adilson., Trigo, Jose Roberto. Scopolamine in Brugmansia suaveolens (Solanaceae): Defense, allocation, costs, and induced response . Journal of chemical ecology, 2007, vol. 33, no. 2, p. 297-309. DOI
Grupta, B. K., Vishwa, Paul., Handa, K. L., Kapoor, L. D. Hyoscine is the chief constituent of Datura suaveolens leaves. proceedings of the national academy of sciences, india, section a: physical sciences, 1965, p. 261-262.
Balbaa, S. I., Saber, A. Hifny., Karawya, M. S., El-Hossary, G. A. Alkaloid content of Datura suaveolens grown in Egypt. journal of pharmaceutical sciences of the united arab republic, 1969, p. 125-134.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature